BRIEF published on 10/28/2024 at 08:05, 24 days 1 hour ago Ondine Biomedical fait progresser la commercialisation de Steriwave Ondine Biomedical Technologie Steriwave Résistance Aux Antimicrobiens Innovation Dans Le Domaine De La Santé Infections Associées Aux Soins De Santé
BRIEF published on 10/28/2024 at 08:05, 24 days 1 hour ago Ondine Biomedical Advances Steriwave Commercialization Antimicrobial Resistance Ondine Biomedical Steriwave Technology Healthcare-associated Infections Innovation In Healthcare
PRESS RELEASE published on 10/28/2024 at 08:00, 24 days 1 hour ago Ondine Continues Commercial Growth Ondine Biomedical Inc. provides updates on the commercial roll-out of its Steriwave® nasal decolonization technology, reducing healthcare-associated infections with light-activated treatment Ondine Biomedical Inc. Nasal Decolonization Steriwave Healthcare-associated Infections Antimicrobial Treatments
BRIEF published on 10/23/2024 at 08:05, 29 days 1 hour ago Ondine Biomedical Inc. Launches Steriwave Pilot at King's College Hospital Steriwave Healthcare Innovation Ondine Biomedical Antimicrobial Treatment King's College Hospital
BRIEF published on 10/23/2024 at 08:05, 29 days 1 hour ago Ondine Biomedical Inc. lance le projet pilote Steriwave au King's College Hospital Steriwave Ondine Biomedical Innovation Dans Le Domaine De La Santé Hôpital King's College Traitement Antimicrobien
PRESS RELEASE published on 10/23/2024 at 08:00, 29 days 1 hour ago Ondine Biomedical Inc. Announces King's College Hospital to Run Steriwave Pilot Ondine Biomedical Inc. collaborates with King's College Hospital to pilot Steriwave® light-activated antimicrobial tech for preventing HAIs. Steriwave rapidly eliminates pathogens without resistance Ondine Biomedical Inc. Steriwave Hospital-acquired Infections Antimicrobial Technology King's College Hospital
BRIEF published on 09/30/2024 at 11:10, 1 month 20 days ago Ondine Biomedical Reports Robust Growth in H1 2024 Clinical Trials Steriwave Ondine Biomedical Financial Growth Hospital Adoption
BRIEF published on 09/30/2024 at 11:10, 1 month 20 days ago Ondine Biomedical annonce une croissance robuste au premier semestre 2024 Croissance Financière Steriwave Ondine Biomedical Essais Cliniques Adoption À L'hôpital
PRESS RELEASE published on 09/30/2024 at 11:05, 1 month 20 days ago Ondine Biomedical Reports Robust Growth in H1 2024 Ondine Biomedical Inc. reports unaudited operational and financial results for the first half of 2024, showing strong revenue growth and strategic partnerships Financial Performance Ondine Biomedical Inc. Strategic Partnership Clinical Trials Operational Results
BRIEF published on 09/30/2024 at 08:05, 1 month 21 days ago Ondine Biomedical annonce une croissance robuste au premier semestre 2024 Résultats Financiers Ondine Biomedical Essais Cliniques Steriwave® Premier Semestre 2024
Published on 11/21/2024 at 09:00, 37 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 2 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 9 hours 12 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 00:00, 9 hours 37 minutes ago Swiss Mining Institute Conference Presentation
Published on 11/20/2024 at 23:00, 10 hours 37 minutes ago Rektron Group Inc. Announces Appointment of a New Director and Provides Corporate Updates
Published on 11/21/2024 at 08:59, 37 minutes ago Black Friday Savings: Kling AI Offers 50% Off and Free Feature Upgrades
Published on 11/21/2024 at 08:59, 37 minutes ago Économies Black Friday : Kling AI propose 50 % de réduction et des mises à niveau gratuites des fonctionnalités
Published on 11/21/2024 at 08:15, 1 hour 22 minutes ago EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%.
Published on 11/21/2024 at 08:09, 1 hour 28 minutes ago KAP HOLDS ITS GROUND IN A DIFFICULT INDUSTRY ENVIRONMENT IN THE FIRST NINE MONTHS OF 2024
Published on 11/21/2024 at 06:58, 2 hours 39 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 39 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 2 hours 39 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 13 hours 30 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 14 hours 17 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
